-
Lilly, BI diabetes drug shows greater A1C reduction in African-American adults than placebo, study shows
RIDGEFIELD, Conn. — A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.
Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced Thursday results of a phase-3 trial of Tradjenta (linagliptin) in which 226 patients with Type 2 diabetes received 5 mg of the drug once per day or placebo.
-
Band-Aid launches Muppet app to take the 'ouch' out of the 'owie'
SKILLMAN, N.J. — Band-Aid brand adhesive bandages on Wednesday unveiled the Band-Aid Brand Magic Vision app featuring Disney's The Muppets. The one-of-a-kind application and platform employs augmented reality technology to provide parents with an ability to entertain their kids during that moment they get hurt. By downloading the app, parents and children can scan any of the Band-Aid brand adhesive bandages strips and boxes featuring Disney's The Muppets and view any of three distinct adventures and performances from the Muppets.